Distribution, Severity and Mortality of COVID-19 in Relation to Blood Group and Rh Factor
Open Access Macedonian Journal of Medical Sciences · 23.05.2026 · 14 (1) · 47-52
DOI: 10.3889/oamjms.2026.12134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access Macedonian Journal of Medical Sciences, online erschienen am 23.05.2026. Verfasst von Gazmend Amzai und 9 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: During the Covid-19 pandemic, a number of investigators reported that in patients with different blood groups the virus had a disparate influence regarding the severity and the outcome of the infection. AIM: The goal of our study was to determine if there is an association between blood groups and Rh factor regarding the severity and mortality from COVID-19 in our analyzed patient population. METHODS: We conducted a retrospective observational study of 250 patients with COVID-19 disease, treated as ambulatory or hospitalized patients in several health facilities during a time period of one year, from November 2020 till November 2021. RESULTS: The majority of patients in our cohort were confirmed to have blood group A - 115 (46%), followed by blood group O - 67 (26.8%) patients, 45 (18%) patients were with blood group B, and 23 (9.2%) patients were with blood group AB. The data generated from our analysis revealed a higher than standard prevalence of SARS-CoV-2 infections among individuals with blood group A. Also, the analysis shows that patients with blood group A experience a more severe clinical course of the disease, as well as higher mortality, compared to patients with other blood groups. There is a substantial difference between Rh positive and Rh negative patients in terms of the severity of the disease. Rh positive patients more frequently experience a severe clinical course, confirmed by statistical significance, but the Rh factor does not affect the outcome of the infection. CONCLUSIONS: The results from our analysis showed that patients with blood group A manifest a more severe clinical course of the disease and a higher mortality rate compared to patients with other blood groups, but statistical significance between them could not be documented.
Zitieren
APA
Amzai, G., Srbinoska-Bogatinoska, M., Karanfilski, O., Stefanoska-Tosheska, G., Kjosevska, T., Grozdanova, E., Muca, A., Proseva, T., Poposka, L., & Dimzova, M. (2026). Distribution, Severity and Mortality of COVID-19 in Relation to Blood Group and Rh Factor. Open Access Macedonian Journal of Medical Sciences, 14(1), 47-52. https://doi.org/10.3889/oamjms.2026.12134
Vancouver
Amzai G, Srbinoska-Bogatinoska M, Karanfilski O, Stefanoska-Tosheska G, Kjosevska T, Grozdanova E, et al. Distribution, Severity and Mortality of COVID-19 in Relation to Blood Group and Rh Factor. Open Access Macedonian Journal of Medical Sciences. 2026;14(1):47-52. doi:10.3889/oamjms.2026.12134
BibTeX
@article{Amzai2026,
author = {Amzai, Gazmend and Srbinoska-Bogatinoska, Milena and Karanfilski, Oliver and Stefanoska-Tosheska, Glorija and Kjosevska, Tatjana and Grozdanova, Eleonora and Muca, Argjent and Proseva, Tatjana and Poposka, Lidija and Dimzova, Marija},
title = {Distribution, Severity and Mortality of COVID-19 in Relation to Blood Group and Rh Factor},
journal = {Open Access Macedonian Journal of Medical Sciences},
year = {2026},
volume = {14},
number = {1},
pages = {47--52},
doi = {10.3889/oamjms.2026.12134}
}
EUVIMED